fashion -WSS

fashion

author：fashion 2025-09-30 22:07:47 - browse：39

Drew Weissman (left) and Katalin Karikó (right) — Drew Weissman (left) and Katalin Karikó, whose longtime partnership was recognized with a Nobel Prize on Monday. Peggy Peterson/Penn Medicine

The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two pioneers of mRNA research was not who won Monday — Katalin Karikó and Drew Weissman were widely expected to get the accolade for discoveries that made it possible to deliver the finicky molecule to cells and enabled the record-breaking development of vaccines that tamed the Covid-19 pandemic. It was the way the two scientists worked together.

The Nobel committee framed Karikó and Weissman’s work as a prime example of complementary expertise, with Karikó focused on RNA-based therapies and Weissman bringing a deep knowledge about immune responses to vaccines. In a rare moment for science’s top honor, which elevates the individual contributions of one, two, or at most, three researchers to a particularly impactful breakthrough, it is a celebration of a true scientific partnership — a durable and fruitful collaboration spanning more than two decades of working shoulder-to-shoulder at the lab bench that turned a scientific backwater into a blockbuster technology.

“We couldn’t get funding, we couldn’t get publications, we couldn’t get people to notice mRNA as something interesting,” Weissman told reporters at a press conference Monday at the University of Pennsylvania. “But Kati lit the match and we spent the rest of the next 20 plus years working together figuring out how to get it to work. We would sit together in 1997 and afterwards and talk about all the things we thought RNA could do. And that’s why we never gave up,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Extensive review finds private equity owners jack up cost of care

WSS

After a decade, new Gardasil ad campaign gets it (mostly) right

Yancopoulos of Regeneron works to expand Dupixent success

Readout Newsletter: Illumina, CRISPR, Regeneron

Medical devices makers are asking for forgiveness, not permission

U.K. officials, researchers try to ease path for bespoke genetic treatments

Yancopoulos of Regeneron works to expand Dupixent success

leisure time

fashion

Wikipedia

What does generative AI mean for health care? We asked experts

Scientists grapple with ethics of stem cell research

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

23andMe had bad news about my health. I wish a person had delivered it

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Jerome Adams on the need for new antivirals for Covid

Diabetes management: Digital health tools fall short, study says

focus

Readout Newsletter: Illumina, CRISPR, Regeneron

Cancer, immunology, HIV research ensnared in fetal tissue politics

Asbestos ban is immediate, but health effects will linger for decades

Chinese researcher claims birth of first gene

Sanders wants to replace patents with prizes for drug inventions

With Wegovy coverage, Medicare patients may face high costs

focus

knowledge

focus

leisure time